9999999995-18-000958.txt : 20180430
9999999995-18-000958.hdr.sgml : 20180430
20180430001514
ACCESSION NUMBER: 9999999995-18-000958
CONFORMED SUBMISSION TYPE: EFFECT
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20180427
DATE AS OF CHANGE: 20180430
EFFECTIVENESS DATE: 20180427
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: EFFECT
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-223739
FILM NUMBER: 18786447
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
EFFECT
1
primary_doc.xml
X0101
EFFECT
33
LIVE
2018-04-27
16:00:00
0001641640
Nabriva Therapeutics plc
333-223739